Back to Bills
HOUSE-BILL 1142119th Congress

HOUSE-BILL 1142: H.R.1142 - To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.

Introduced: February 7, 2025
Status: Referred to Committee
Authority Conflict

AI-Powered Summary

Generated by AI Analysis

HOUSE-BILL 1142 aims to enhance medication adherence among Medicare beneficiaries by establishing guidelines that target a 90% adherence rate for Medicare Part B and D drugs. The bill addresses major themes such as health care access, the promotion of generic and biosimilar drugs to reduce costs, and the integration of artificial intelligence and machine learning in health care practices. Key provisions include the responsibility of the Secretary of Health and Human Services to create these adherence guidelines, which may improve access to medications but could also raise privacy and ethical concerns related to data usage. The implementation of these guidelines is expected to be monitored closely, potentially increasing scrutiny on individual health behaviors, which may impact personal autonomy. The legislation also raises constitutional questions regarding the right to health care access and the limits of federal authority in regulating health care, as well as concerns about discrimination and privacy under the Fourth Amendment.

Demographic Impact Analysis

AI Demographics Analysis

Summary

Overall Constitutional Implications

The bill's provisions could lead to significant government involvement in healthcare regulation, which may infringe upon individual rights related to health care access and equality. The potential for unequal access to medications based on demographic factors could exacerbate existing disparities in healthcare.

Key Individual Rights Affected

  • Right to Health Care
  • Equal Protection under the Law

Constitutional Provisions

  • Fourteenth Amendment (Equal Protection Clause)
  • Due Process Clause

Potential Constitutional Challenges

The bill may face challenges if it is found to disproportionately impact certain demographic groups, particularly racial and ethnic minorities, low-income individuals, and seniors. The use of AI and machine learning in determining medication adherence could also raise issues of algorithmic bias and discrimination.

Summary

HOUSE-BILL 1142 aims to improve medication adherence through the use of technology and the promotion of generics, but it raises significant constitutional concerns regarding government overreach and equal protection. The bill's impact will vary across demographic groups, with vulnerable populations potentially facing greater barriers to access. Ensuring equitable implementation will be crucial to avoid infringing upon individual rights.

Constitutional Analysis

Authority Conflict

This bill has been analyzed for constitutional compliance using AI-powered analysis of constitutional principles and precedents.

Analysis generated using AI-powered review of constitutional principles and legal precedents.

Take Action

Text 50409

💡 How to use:

These links will start a conversation with ResistBot. When prompted, mention H.R. 1142 to reference this bill.

Contact Your Representatives

Write to YOUR elected officials about this bill

Rate This Bill

Sign in to save a private rating for this bill and track your civic engagement over time.

Sign In Free

Timeline

February 7, 2025

Bill Introduced

Current

Referred to Committee

June 12, 2026

Last Updated

Ask the Constitutional AI About This Bill

Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.

Sign In Free to Chat